APOL1 Mediated Kidney Disease Market SWOT analysis and Key Business Strategies, Demand & Forecast

1. APOL1 Mediated Kidney Disease Market 2021 Growth, COVID Impact, SWOT Analysis, Trends & Report 2027 | FMI Report April 2021 Report Id : REP-GB-12115 Published On: Category : Healthcare, Pharmaceuticals & Medical Devices 2021-03-08 www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved

2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the worldto distillit to one thing – the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Social Media Research Email: hari.t@futuremarketinsights.com www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 2 © 2019 Future Market Insights, All Rights Reserved

3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 FMI formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Developing list of respondents Channel study B Developments 4 FMI conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Market dynamics Data collection Products      Market participants C Conclusions Key strengths Company Analysis Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data 5 Product portfolio Data validation Mapping as per value chain Key focus segments 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 FMI delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 3 © 2019 Future Market Insights, All Rights Reserved

4. APOL1 Mediated Kidney Disease Market Analysis ESOMAR-certified Future Market Insights' recent APOL-1 mediated kidney disease market report forecasts a healthy growth outlook through 2021 and beyond. As of 2020, the market was valued at US$ 3 billion, majorly bolstered by ongoing active clinical pipeline projects to discover potentially new drug candidates. Future projections indicate a positive forecast, with an anticipated CAGR exceeding 4% through 2031. According to the National Kidney Foundation, as of 2015, 10% of the global population was affected by chronic kidney disease. As of 2019, over 750 million people were impacted. Consequently, research and development spending to address this burden has inclined in recent years. Between 2016 and 2017, global R&D spending amounted to nearly 4%, costing around US$ 97.2 billion. Such promising figures are opening up future investment opportunities by prospective pharmaceutical giants. Recently, in February 2021, British pharmaceutical giant AstraZeneca received marketing authorization to advocate its anti-diabetic drug dapagliflozin for treating patients in India suffering from chronic kidney disease. The company has already made significant strides, negotiating an over US$ 300 million licensing agreement with Ionis Pharmaceuticals for two pipeline antisense therapies in 2018. The candidate under investigation is the AZD2373 for treating the original cause of APOL-1 CKDs. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 4 © 2019 Future Market Insights, All Rights Reserved

5. APOL1 Mediated Kidney Disease Market Analysis "As the global chronic kidney diseases burden increases, R&D projects to accelerate potential drug candidate availability are rising, generating massive revenue pools across key markets, heightening growth prospects," says the FMI analyst. Request a report sample with 95 pages to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-12115 Key Takeaways from FMI's APOL-1 Mediated Kidney Disease Market Study By indication, focal segmental glomerulosclerosis (FSGS) to remain the primary therapeutic domain US to experience elevated growth prospects amid rising frequencies of ongoing multiple stage small molecule inhibitor clinical trials Foray for investigating effective diagnosis to prevent end stage renal disease (ESRD) spurring APOL-1 mediated kidney disease treatment in the UK Germany & France concentrating on providing affordable nephrology care, thus widening growth scope High prevalence of diabetic neuropathy is compelling patients to seek treatment for kidney disorders, broadening growth prospects across India www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 5 © 2019 Future Market Insights, All Rights Reserved

6. APOL1 Mediated Kidney Disease Market Analysis APOL-1 Mediated Kidney Disease Market- Prominent Drivers Preference for small molecule genetics is catapulting growth prospects for APOL-1 mediated kidney disease treatment Highly consolidated landscape is paving way for future penetration by new players, broadening research capabilities Broader budgetary allocation to facilitate increased research is expected to propel the market forward APOL-1 Mediated Kidney Disease Market- Key Restraints Rapid genetic mutations may render it difficult to develop a standardized treatment approach, thereby hindering growth prospects Limited awareness regarding the onset of chronic kidney disorders leads to quick progression towards ESRD, rendering effective treatment difficult Click here to Order a free sample www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 6 © 2019 Future Market Insights, All Rights Reserved

7. APOL1 Mediated Kidney Disease Market Analysis Discover more about the APOL-1 mediated kidney disease market with 15 figures and 4 data tables, along with the table of contents. You will also find detailed market segmentation on https://www.futuremarketinsights.com/reports/apol-1-mediated-kidney-disease-market Competitive Landscape Prominent players featured in FMI's APOL-1 mediated kidney disease market include Vertex Pharmaceuticals Incorporated, Ionis Pharmaceuticals Inc. (AstraZeneca), Retrophin Inc., ChemoCentryx Inc., Variant Pharmaceuticals Inc., GlaxoSmithKline Plc., Novartis AG and Teva Pharmaceuticals Ltd. among others. Majority of these players are emphasizing on developing small molecule inhibitors to prevent the onset of the disease. In October 2020, Vertex Pharmaceuticals announced it was working on the VX-147 small molecule inhibitor for APOL-1 mediated focal segmental glomerulosclerosis (FSGS), which entered its Phase 2 clinical trial. Likewise, in May 2020, ChemoCentryx Inc. announced topline data from a 46 patient Phase II dose- ranging trial for primary FSGS titled LUMINA-1. The trial tested CCX140, an orally administered selective inhibitor of the CCR2 chemokine receptor, the main trigger for the disease. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 7 © 2019 Future Market Insights, All Rights Reserved

8. APOL1 Mediated Kidney Disease Market Analysis More Insights on FMI's APOL-1 Mediated Kidney Disease Market Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016-2020 and forecast from 2021-2031. The global APOL1 mediated kidney disease market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on APOL1 mediated kidney disease market on basis of indication (chronic kidney disease and end stage kidney disease) across North America, Europe and Middle East and Africa. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 8 © 2019 Future Market Insights, All Rights Reserved

9. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 9 © 2019 Future Market Insights, All Rights Reserved